Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Price: 13.37 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 13.14 | 13.50 | 13.13 | 13.37 | 8.249M |
Nov 21, 2024 | 13.20 | 13.32 | 13.10 | 13.25 | 6.962M |
Nov 20, 2024 | 12.97 | 13.22 | 12.94 | 13.13 | 8.773M |
Nov 19, 2024 | 12.92 | 13.07 | 12.79 | 13.05 | 7.386M |
Nov 18, 2024 | 12.78 | 13.06 | 12.68 | 13.00 | 9.025M |
Nov 15, 2024 | 12.63 | 12.87 | 12.53 | 12.83 | 9.152M |
Nov 14, 2024 | 12.95 | 13.09 | 12.58 | 12.62 | 6.457M |
Nov 13, 2024 | 12.85 | 13.02 | 12.83 | 13.00 | 8.249M |
Nov 12, 2024 | 13.00 | 13.17 | 12.86 | 12.93 | 8.345M |
Nov 11, 2024 | 13.06 | 13.21 | 12.79 | 13.09 | 10.04M |
Nov 08, 2024 | 13.07 | 13.21 | 12.73 | 12.96 | 8.943M |
Nov 07, 2024 | 11.81 | 13.44 | 11.67 | 13.18 | 22.18M |
Nov 06, 2024 | 11.87 | 12.01 | 11.58 | 11.61 | 11.59M |
Nov 05, 2024 | 11.44 | 11.63 | 11.33 | 11.61 | 5.302M |
Nov 04, 2024 | 11.59 | 11.70 | 11.42 | 11.45 | 5.307M |
Nov 01, 2024 | 11.67 | 11.76 | 11.58 | 11.62 | 5.349M |
Oct 31, 2024 | 11.88 | 11.90 | 11.59 | 11.60 | 8.053M |
Oct 30, 2024 | 11.67 | 11.96 | 11.65 | 11.89 | 4.765M |
Oct 29, 2024 | 11.69 | 11.78 | 11.63 | 11.74 | 4.803M |
Oct 28, 2024 | 11.52 | 11.79 | 11.48 | 11.76 | 5.020M |
Oct 25, 2024 | 11.56 | 11.68 | 11.43 | 11.44 | 3.180M |
Oct 24, 2024 | 11.56 | 11.64 | 11.42 | 11.48 | 4.068M |
Oct 23, 2024 | 11.63 | 11.72 | 11.49 | 11.55 | 3.470M |
Oct 22, 2024 | 11.54 | 11.71 | 11.52 | 11.67 | 4.077M |
Oct 21, 2024 | 11.76 | 11.81 | 11.57 | 11.57 | 3.714M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.48
Minimum
Sep 27 2022
22.85
Maximum
Feb 05 2020
13.02
Average
11.94
Median
Jan 30 2023
Price Benchmarks
Lexicon Pharmaceuticals Inc | 0.8634 |
Moderna Inc | 41.11 |
Baxter International Inc | 33.21 |
Gilead Sciences Inc | 90.19 |
Perspective Therapeutics Inc | 3.47 |
Price Related Metrics
PS Ratio | 1.069 |
Price to Book Value | 0.8063 |
Price to Free Cash Flow | 8.496 |
Earnings Yield | -5.53% |
Market Cap | 15.96B |
Operating PE Ratio | 74.67 |